Regulation of sphingolipid and glycosphingolipid metabolism in extrahepatic tissues by endotoxin.
The host response to infection and inflammation is associated with multiple alterations in lipid metabolism. We have shown that endotoxin [lipopolysaccharide (LPS)] stimulates hepatic sphingolipid synthesis and increases ceramide and glucosylceramide (GlcCer) content in circulating lipoproteins in Syrian hamsters. LPS also increases the activity and mRNA levels of serine palmitoyltransferase (SPT) and GlcCer synthase, the committed enzymes in sphingolipid and glycosphingolipid (GSL) synthesis, respectively, in the liver. To determine whether sphingolipid and GSL metabolism are regulated in other tissues during the host response to infection, we examined the effect of LPS on the regulation of SPT and GlcCer synthase in extrahepatic tissues in Syrian hamsters. LPS significantly increased SPT activity in spleen and kidney after 16 h of treatment, but had no effect on SPT activity in lung and brain, suggesting that the effect of LPS on sphingolipid metabolism is tissue specific. LPS also increased SPT mRNA levels in spleen and kidney by approximately 3-fold, suggesting that the increase in SPT activity is due to an increase in SPT mRNA expression. LPS significantly increased GlcCer synthase activity in spleen and kidney, and produced 4- and 15-fold increases in GlcCer synthase mRNA levels in spleen and kidney, respectively. LPS treatment increased GlcCer content by 1.3-fold in spleen and by 6.2-fold in kidney. LPS also increased the content of ceramide trihexoside by 1.7-fold in spleen. These results suggest that LPS regulates sphingolipid and GSL metabolism in spleen and kidney. An increase in GSL metabolites in spleen and kidney during the host response to infection and inflammation may be required for modulation of immune responses and regulation of cell growth. -- Memon, R. A., W. M. Holleran, Y. Uchida, A. H. Moser, C. Grunfeld, and K. R. Feingold. Regulation of sphingolipid and glycosphingolipid metabolism in extrahepatic tissues by endotoxin. J. Lipid Res. 2001. 42: 452--459.
Memon
R A
RA
Department of Medicine, University of California, San Francisco, CA 94143, USA. rmemon@itsa.ucsf.edu
Holleran
W M
WM
Uchida
Y
Y
Moser
A H
AH
Grunfeld
C
C
Feingold
K R
KR
D000217:Acyltransferases / Q000235:genetics / Q000378:metabolism; D000818:Animals; D015152:Blotting, Northern; D001921:Brain / Q000201:enzymology; D006224:Cricetinae; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D005964:Glucosyltransferases / Q000235:genetics / Q000378:metabolism; D006028:Glycosphingolipids / Q000378:metabolism*; D007668:Kidney / Q000201:enzymology; D007700:Kinetics; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008168:Lung / Q000201:enzymology; D008297:Male; D008647:Mesocricetus; D012333:RNA, Messenger / Q000032:analysis; D051102:Serine C-Palmitoyltransferase; D013107:Sphingolipids / Q000378:metabolism*; D013154:Spleen / Q000201:enzymology
D006028:Glycosphingolipids; D008070:Lipopolysaccharides; D012333:RNA, Messenger; D013107:Sphingolipids; D000217:Acyltransferases; D051102:Serine C-Palmitoyltransferase; D005964:Glucosyltransferases; C023246:ceramide glucosyltransferase